Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

Market Cap	25.72B +61.4%
Revenue (ttm)	1.66B -17.9%
Net Income	297.84M +302.1%
EPS	0.40 +300.0%
Shares Out	733.37M
PE Ratio	94.15
Forward PE	76.28
Dividend	0.12 (0.32%)
Ex-Dividend Date	Aug 14, 2025

Volume	279,700
Average Volume	35,839,695
Open	36.60
Previous Close	36.93
Day's Range	36.40 - 38.20
52-Week Range	15.12 - 45.95
Beta	0.92
RSI	55.85
Earnings Date	Mar 30, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,551
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.